Gyeonggi-do to Offer Free 'Novavax XBB.1.5' Vaccinations Starting the 18th

Gyeonggi Provincial Government

Gyeonggi Province will begin administering the COVID-19 updated vaccine ‘XBB.1.5’, developed by Novavax using a recombinant antigen method, starting from the 18th.

This vaccine is a recombinant antigen vaccine produced using genetic recombination technology, the same production method used for hepatitis B and influenza vaccines. It received emergency use authorization from the U.S. Food and Drug Administration (FDA) on October 3rd and approval from the European Medicines Agency (EMA) on October 31st.

All individuals aged 12 and older who are at least 3 months (90 days) past their last COVID-19 vaccination can receive the vaccine free of charge.

Vaccinations can be administered by visiting vaccination centers after confirming stock availability or by making an appointment online at ncv.kdca.go.kr and then receiving the vaccine.

To check vaccination centers, visit the COVID-19 Vaccination Portal at ncv.kdca.go.kr.

While the fatality rate from COVID-19 infection is 40 times higher for those aged 65 and older compared to those under 65, vaccination can reduce the risk of hospitalization and death by a factor of 20.

Nosuk Hyun, head of the Infectious Disease Control Support Group in Gyeonggi Province, stated, "COVID-19 remains a threatening disease for high-risk groups such as those aged 65 and older," and urged, "Please actively participate in vaccinations to prepare for the spread of respiratory infectious diseases such as COVID-19 and influenza."

This content was produced with the assistance of AI translation services.